December 27, 2017
Today in #QualityFraud North Carolina Sues Insys For Pushing Opioids
December 11, 2017
FDA’s Response to Opioid Crisis? More Meds for Big Pharma.
What is Product Liability?
Back around the time that the Occupy Movement was gaining steam, I traveled to Cleveland to depose a corporate lawyer about his work for a hoist manufacturer. I remember getting thrown out of the Rock and Roll Hall of Fame for taking photos of the Cher exhibit for Missi. In my defense, however, it was […]
November 16, 2017
A new resource for keeping track of Big Pharma. #QualityFraud Tarbell: investigations into high drug prices
October 17, 2017
Opioid makers capture Congress and the DEA Congress Eliminates DEA Oversight
Tasting
The fifth – and mercifully final – in the series of blogs about how the Senses play out in litigation. I confess – I am at a loss on this one. But having given myself the task, I am determined to complete it. To state the obvious, there aren’t a lot of cases in my […]
10/2/2017
How does the FDA classify drugs and products for regulation? FDA Final Guidance to Industry and Staff
Touching
The fourth in a series about the Senses in litigation. The sense of touch is varied and wondrous. Through touch, we appreciate temperature, texture of surface, shape, hardness or softness, elasticity and even weight. Touch is the one sense used from the beginning to the end of a personal injury case. Investigating cases I’ve sifted through roadway debris, patrolled junk […]
July 19, 2017
Despite tax breaks for R&D, Big Pharma spends more money pumping up stock value with buybacks than they spend on research and development. Drug Prices Are Not Based on R&D
June 7, 2017
Today in Quality Fraud: Endoscope Maker, Olympus, settles for harms caused by gynecologic surgical tool that spreads cancer cells – following a 2016 $646M criminal/civil settlement with the Feds over a bribery and kickback scheme. 2016 Federal Criminal Bribery and Kickback Settlement by Olympus